BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25659280)

  • 1. Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness.
    Jackson ML; Rothman KJ
    Vaccine; 2015 Mar; 33(11):1313-6. PubMed ID: 25659280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination.
    Shi M; An Q; Ainslie KEC; Haber M; Orenstein WA
    BMC Infect Dis; 2017 Dec; 17(1):757. PubMed ID: 29216845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of selection bias on vaccine effectiveness estimates from test-negative studies.
    Jackson ML; Phillips CH; Benoit J; Kiniry E; Madziwa L; Nelson JC; Jackson LA
    Vaccine; 2018 Jan; 36(5):751-757. PubMed ID: 29254838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The test-negative design for estimating influenza vaccine effectiveness.
    Jackson ML; Nelson JC
    Vaccine; 2013 Apr; 31(17):2165-8. PubMed ID: 23499601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.
    Orenstein EW; De Serres G; Haber MJ; Shay DK; Bridges CB; Gargiullo P; Orenstein WA
    Int J Epidemiol; 2007 Jun; 36(3):623-31. PubMed ID: 17403908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of self-reported vaccination status can bias vaccine effectiveness estimates from test-negative studies.
    Jackson ML
    Vaccine X; 2019 Apr; 1():100003. PubMed ID: 33826685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the bias of estimates of influenza vaccine effectiveness from test-negative studies.
    Ainslie KEC; Shi M; Haber M; Orenstein WA
    Vaccine; 2017 Dec; 35(52):7297-7301. PubMed ID: 29146382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The case test-negative design for studies of the effectiveness of influenza vaccine.
    Foppa IM; Haber M; Ferdinands JM; Shay DK
    Vaccine; 2013 Jun; 31(30):3104-9. PubMed ID: 23624093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Dynamic Model for Evaluation of the Bias of Influenza Vaccine Effectiveness Estimates From Observational Studies.
    Ainslie KEC; Shi M; Haber M; Orenstein WA
    Am J Epidemiol; 2019 Feb; 188(2):451-460. PubMed ID: 30329006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic principles of test-negative design in evaluating influenza vaccine effectiveness.
    Fukushima W; Hirota Y
    Vaccine; 2017 Aug; 35(36):4796-4800. PubMed ID: 28818471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bias due to differential and non-differential disease- and exposure misclassification in studies of vaccine effectiveness.
    De Smedt T; Merrall E; Macina D; Perez-Vilar S; Andrews N; Bollaerts K
    PLoS One; 2018; 13(6):e0199180. PubMed ID: 29906276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings.
    Foppa IM; Ferdinands JM; Chaves SS; Haber MJ; Reynolds SB; Flannery B; Fry AM
    Int J Epidemiol; 2016 Dec; 45(6):2052-2059. PubMed ID: 26979985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors.
    Doll MK; Pettigrew SM; Ma J; Verma A
    Clin Infect Dis; 2022 Aug; 75(1):e564-e571. PubMed ID: 35325923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination.
    Ferdinands JM; Shay DK
    Clin Infect Dis; 2012 Jan; 54(1):25-32. PubMed ID: 22095567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons.
    Thompson MG; Li DK; Shifflett P; Sokolow LZ; Ferber JR; Kurosky S; Bozeman S; Reynolds SB; Odouli R; Henninger ML; Kauffman TL; Avalos LA; Ball S; Williams JL; Irving SA; Shay DK; Naleway AL;
    Clin Infect Dis; 2014 Feb; 58(4):449-57. PubMed ID: 24280090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A probability model for evaluating the bias and precision of influenza vaccine effectiveness estimates from case-control studies.
    Haber M; An Q; Foppa IM; Shay DK; Ferdinands JM; Orenstein WA
    Epidemiol Infect; 2015 May; 143(7):1417-26. PubMed ID: 25147970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic.
    Ainslie KEC; Haber M; Orenstein WA
    Vaccine; 2019 Mar; 37(14):1987-1993. PubMed ID: 30833155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2).
    Valenciano M; Kissling E; Reuss A; Jiménez-Jorge S; Horváth JK; Donnell JM; Pitigoi D; Machado A; Pozo F;
    Vaccine; 2015 Jun; 33(24):2813-22. PubMed ID: 25936723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in estimating influenza vaccine effectiveness.
    Ainslie KEC; Haber M; Orenstein WA
    Expert Rev Vaccines; 2019 Jun; 18(6):615-628. PubMed ID: 31116070
    [No Abstract]   [Full Text] [Related]  

  • 20. Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings.
    Feng S; Cowling BJ; Sullivan SG
    Vaccine; 2016 Mar; 34(14):1672-9. PubMed ID: 26920469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.